Research Interest: Molecular Medicine

PHD PROGRAM
Genetics & Molecular Biology, Pharmacology

RESEARCH INTEREST
Biophysics, Cell Biology, Gene Therapy, Molecular Medicine, Neurobiology, Pharmacology, Physiology, Virology

My research is focuses on two general areas: 1) Molecular principles of auditory information processing, and 2) Gene Therapy approaches to treat neurological disorders. In regard to our auditory focus, we seek to understand how the molecular machinery in auditory brainstem synapses enables neuronal computations at some of the fastest speeds in the central nervous system to enable the ability to identify and interpret sound information received by the ears. In regard to our gene therapy approaches, we seek to develop novel viral vector technology to create novel therapeutic strategies to treat neuronal dysfunction and degeneration to improve the quality of life of individuals who suffer from neurological diseases. To address these research areas, I employ a multi-disciplinary strategy that encompasses, molecular biology, virology, viral vectors, biophysics, light microscopy, electron microscopy, electrophysiology, and transgenic mouse models.

Keywords: Gene therapy, synaptic transmission, Hearing, viral vectors, biophysics, ion channels, calcium signaling, neurodegeneration, molecular medicine, synaptic plasticity, molecular engineering, nanomedicine

PHD PROGRAM

RESEARCH INTEREST
Molecular Medicine, Neurobiology, Translational Medicine

“I am interested in studying networks of different cell types during neurodevelopment as well as neurodegeneration, as two sides of the same coin, in order to understand how a healthy network responds to be able to influence therapy. I am particularly interested in using novel and/or improved molecular vectors, to develop new therapeutical approaches, and to investigate new technological advances.”

PHD PROGRAM

RESEARCH INTEREST
Drug Delivery, Molecular Medicine, Translational Medicine

“I am interested in improving the delivery of biologics and small molecules to their targets through nanoparticle, biomolecular and cellular engineering. Specifically, I would like to address the difficulties associated with drug delivery to the brain or mitigate the off-target effects of oncoimmune therapies.”

PHD PROGRAM

RESEARCH INTEREST
Cell-Based Therapy, Gene Therapy, Molecular Medicine, Pathology, Translational Medicine

“I am interested in the pathology behind genetic disorders as well as the development of new treatment methods such as gene/cell therapies, stem cell therapies, and immunotherapy. I am also interested in researching novel therapeutic delivery systems with a goal of translating discovery into clinical settings.”

PHD PROGRAM
Biochemistry & Biophysics

RESEARCH INTEREST
Biochemistry, Biophysics, Cancer Biology, Molecular Medicine, Structural Biology

Our lab is interested in the molecular mechanisms of adaptive stress responses. These responses to environmental or metabolic stress are essential for survival but frequently dysregulated in disease. We use an integrated approach combining biophysical, structural, and biochemical methods to investigate the roles of intrinsically disordered proteins and dynamic enzymes that orchestrate these critical stress responses, with the ultimate goal of developing new approaches for modulating the functions of dynamic molecules.

PHD PROGRAM
Microbiology & Immunology

RESEARCH INTEREST
Genetics, Genomics, Molecular Biology, Molecular Medicine, Pathogenesis & Infection

Dr. Lin is an infectious disease physician-scientist whose research lies at the interface of clinical and molecular studies on malaria. My current projects focus on 1) determinants of malaria transmission from human hosts to mosquitos and 2) the epidemiology and relapse patterns of Plasmodium ovale in East Africa. Work in my lab involves applying molecular tools (real-time PCR, amplicon deep sequencing, whole genome sequencing, and to a lesser extent antigen and antibody assays) to samples collected in clinical field studies to learn about malaria epidemiology, transmission, and pathogenesis.

PHD PROGRAM
Biochemistry & Biophysics, Chemistry

RESEARCH INTEREST
Biochemistry, Drug Delivery, Drug Discovery, Molecular Medicine, Nanomedicine

My research has focused on developing new radio-chemistry, imaging probes, and therapeutic approaches including nanomedicine for various diseases. Most importantly, we have the culture of forming an active collaboration with people in different field. With a cGMP lab located within our facility, we are also experienced on developing lead agents and translate it to clinic.

PHD PROGRAM
Cell Biology & Physiology

RESEARCH INTEREST
Bioinformatics, Cardiovascular Biology, Cell Biology, Genetics, Molecular Medicine

Our lab uses human genetics to identify new mechanisms driving coronary artery disease (CAD). Starting with findings from genome-wide association studies (GWAS) of CAD, we identify the causal gene at a given locus, study the effect of this gene on cellular and vessel wall biology, and finally determine the molecular pathways by which this gene influences CAD risk. Within this framework, we use complex genetic mouse models and human vascular samples, single-cell transcriptomics/epigenomics and high-throughput CRISPR perturbations, as well as traditional molecular biology techniques.

PHD PROGRAM
Biochemistry & Biophysics

RESEARCH INTEREST
Behavior, Biochemistry, Cell Biology, Cell Signaling, Chemical Biology, Drug Discovery, Immunology, Metabolism, Molecular Biology, Molecular Medicine, Neurobiology, Pathogenesis & Infection, Pharmacology, Translational Medicine, Virology

Antiretroviral therapy (ART) is effective in suppressing HIV-1 replication in the periphery, however, it fails to eradicate HIV-1 reservoirs in patients. The main barrier for HIV cure is the latent HIV-1, hiding inside the immune cells where no or very low level of viral particles are made. This prevents our immune system to recognize the latent reservoirs to clear the infection. The main goal of my laboratory is to discover the molecular mechanisms how HIV-1 achieves its latent state and to translate our understanding of HIV latency into therapeutic intervention.

Several research programs are undertaking in my lab with a focus of epigenetic regulation of HIV latency, including molecular mechanisms of HIV replication and latency establishment, host-virus interaction, innate immune response to viral infection, and the role of microbiome in the gut health. Extensive in vitro HIV latency models, ex vivo patient latency models, and in vivo patient and rhesus macaque models of AIDS are carried out in my lab. Multiple tools are applied in our studies, including RNA-seq, proteomics, metabolomics, highly sensitive digital droplet PCR and tissue RNA/DNAscope, digital ELISA, and modern and traditional molecular biological and biochemical techniques. We are also very interested in how non-CD4 expression cells in the Central Nervous System (CNS) get infected by HIV-1, how the unique interaction among HIV-1, immune cells, vascular cells, and neuron cells contributes to the initial seeding of latent reservoirs in the CNS, and whether we can target the unique viral infection and latency signaling pathways to attack HIV reservoirs in CNS for a cure/remission of HIV-1 and HIV-associated neurocognitive disorders (HAND). We have developed multiple tools to attack HIV latency, including latency reversal agents for “Shock and Kill” strategy, such as histone deacetylase inhibitors and ingenol family compounds of protein kinase C agonists, and latency enforcing agents for deep silencing of latent HIV-1. Several clinical and pre-clinical studies are being tested to evaluate their potential to eradicate latent HIV reservoirs in vivo. We are actively recruiting postdocs, visiting scholars, and technicians. Rotation graduate students and undergraduate students are welcome to join my lab, located in the UNC HIV Cure Center, for these exciting HIV cure research projects.

PHD PROGRAM
Pathobiology & Translational Science

RESEARCH INTEREST
Cancer Biology, Cell Biology, Molecular Medicine, Pathology, Translational Medicine

My research lab focuses on the molecular pathogenesis of endometrial cancer, the most common gynecologic cancer in the Western world. Current projects include developing molecular diagnostics for predicting endometrial cancer histotype, stage, and recurrence; developing clinical and lab-based algorithms for the identification of patients with hereditary endometrial cancer (Lynch Syndrome); discovering novel molecular mediators of endometrial cancer invasion and metastasis; identifying signaling pathways important in the pathogenesis of endometrial cancer; and identifying molecular determinants of health disparities in endometrial cancer.